460940.KQ
P&S Robotics Co., Ltd.
KOE · Healthcare · Medical - Specialties · KR
KRW 4,860.00
−3.19%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 5.6B | 7.6B | 7.1B | 6.0B | 5.2B |
| Cost of Revenue | 2.5B | 2.6B | 2.5B | 2.3B | 1.7B |
| Gross Profit | 3.1B | 5.0B | 4.6B | 3.7B | 3.5B |
| Operating Expenses | |||||
| R&D Expense | 1.2B | 1.1B | 795.5M | 475.7M | 256.3M |
| SG&A Expense | 3.3B | 2.9B | 812.9M | 887.6M | 541.1M |
| General & Admin Expense | 1.3B | 754.3M | 472.7M | 389.8M | 261.2M |
| Selling & Marketing Expense | 100.4M | 589.7M | 340.2M | 497.9M | 279.9M |
| Other Expenses | (82.6M) | — | 1.4B | 1.0B | 60.0M |
| Total Operating Expenses | 4.4B | 4.0B | 3.0B | 2.4B | 1.5B |
| Cost and Expenses | 6.9B | 6.6B | 5.5B | 4.7B | 3.2B |
| Operating Income (EBIT) | (1.3B) | 1.0B | 1.6B | 1.3B | 2.0B |
| Non-Operating | |||||
| Interest Income | 892.1M | 974.3M | 628.7M | 154.1M | 58.2M |
| Interest Expense | 36.5M | 33.0M | 23.9M | 41.2M | 76.5M |
| Net Interest Income | 855.6M | 941.3M | 604.8M | 112.9M | (18.2M) |
| Other Non-Op Income/Expense | 1.4B | 1.1B | 931.5M | 160.5M | (334.8M) |
| Non-Operating Income (excl Interest) | (30.00) | (1.2B) | (955.4M) | (201.6M) | 258.4M |
| EBT (Pre-Tax Income) | 44.2M | 2.1B | 2.5B | 1.5B | 1.7B |
| Income Tax Expense | (1.2B) | (601.4M) | 225.8M | 69.7M | 177.2M |
| Bottom Line | |||||
| Net Income | 1.3B | 2.7B | 2.3B | 1.4B | 1.5B |
| Earnings from Cont. Ops | 1.3B | 2.7B | 2.3B | 1.4B | 1.5B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 1.3B | 2.7B | 2.3B | 1.4B | 1.5B |
| Per Share | |||||
| Basic EPS | ₩98 | ₩212 | ₩205 | ₩139 | ₩148 |
| Diluted EPS | ₩98 | ₩207 | ₩197 | ₩135 | ₩147 |
| Revenue Per Share | ₩414 | ₩582 | ₩627 | ₩591 | ₩513 |
| Shares | |||||
| Basic Shares Outstanding | 13.5M | 13.1M | 11.3M | 10.2M | 10.2M |
| Diluted Shares Outstanding | 13.5M | 13.1M | 11.8M | 10.4M | 10.2M |
| Profitability Metrics | |||||
| EBITDA | (1.0B) | 1.2B | 2.7B | 1.6B | 1.9B |
| D&A | 299.6M | 232.5M | 136.9M | 118.0M | 102.1M |
| EBIT | (1.3B) | 1.0B | 2.6B | 1.5B | 1.8B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026